More so, with neutrophil migration and cell death (IL-1α) contributing much to COVID-19 pathology (Gupta 2020a, b), suPAR can be a better early biomarker than non-specific markers (PCT/CRP) for COVID-19 progression. The gene discussed is CRP; the disease is COVID-19.